Evidence map›Paper›PMID 41028722›Full record

ArticleNPJ Parkinson's disease2025

Thalamic nuclei volume changes associated with cognitive and motor manifestations of Parkinson's disease.

Vicente J Ferrer-Gallardo, Teresa Esteban-Peñalba, Maria C Rodriguez-Oroz, César Caballero-Gaudes, Pedro M Paz-Alonso

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vicente J Ferrer-GallardoBCBL. Basque Center on Cognition Brain and Language, Donostia, Spain. vferrer@bcbl.eu.
Teresa Esteban-PeñalbaBCBL. Basque Center on Cognition Brain and Language, Donostia, Spain.
Maria C Rodriguez-OrozNeurology Department, Clínica Universidad de Navarra, Pamplona, Spain.
César Caballero-GaudesBCBL. Basque Center on Cognition Brain and Language, Donostia, Spain.
Pedro M Paz-AlonsoBCBL. Basque Center on Cognition Brain and Language, Donostia, Spain. kepa.pazalonso@gmail.com.

Funding

Basque Government BERC 2022-2025 programBasque Government predoctoral fellowship PRE_2019_1_0085'la Caixa' Foundation ID 100010434Spanish Ministry of Economy and Competitiveness BES-2016-079489Spanish Ministry of Science and Innovation PID2021-123574NB-I00Spanish Ministry of Science and Innovation PID2023-149410b-100Spanish State Research Agency through BCBL Severo Ochoa excellence accreditation CEX2020-001010-S
6 · The paper itself

Abstract

Motor and cognitive symptoms are key features of Parkinson's disease (PD), which typically appear over time as the disease progresses. The thalamus, a central hub within basal ganglia-thalamocortical circuits, plays a crucial role in motor, sensory, and cognitive functions. This study examined thalamic nuclei volume and lateralization in individuals with PD and healthy controls, and explored their associations with cognitive and motor measures using partial least squares analysis. We found that cognitive alterations were linked to volume changes in specific nuclei of the anterior, ventral, medial, and posterior thalamic nuclear groups. Notably, the anteroventral and ventral posterolateral nuclei showed strong associations with the Montreal Cognitive Assessment used to assess mild cognitive impairment. Motor impairment was associated with volume lateralization asymmetries in the centromedian, mediodorsal medial, pulvinar anterior, and pulvinar medial nuclei. These findings underscore the multifaceted role of the thalamus in the motor and cognitive manifestations of this neurodegenerative disorder.

Identifiers

PMID41028722
PMCPMC12484683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.